NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA) today announced strong results for the first fiscal quarter ended June 30, 2008. Total revenue for the first quarter rose 39% to $9.2 million from $6.6 million for the same period a year ago. Revenue for Clinical Data’s PGxHealth division grew at a record 114% percent to $2.0 million, including a 122% increase in sales of PGxHealth’s FAMILION® and PGxPredict® tests. Total Cogenics revenue also grew substantially by 26% compared to the same period last year.
